Literature DB >> 29946167

Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation.

Yong-Jian Hu1, Qian Sun1, Wen-Hua Zhang1, Yu-Jia Huo1, Chan-Juan Xu2, Jian-Feng Liu3.   

Abstract

Metabotropic glutamate receptor 2 (mGlu2) belongs to the group-II metabotropic glutamate (mGlu) receptors and is a neurotransmitter G protein-coupled receptor. The group-II mGlu receptors are promising antipsychotic targets, but the specific role of mGlu2 signaling remains unclear. Receptor tyrosine kinases (RTKs) are also believed to participate in brain pathogenesis. To investigate whether there is any communication between mGlu2 and RTKs, we generated a CHO-mGlu2 cell line that stably expresses mGlu2 and showed that activation of mGlu2 by LY379268, a group II mGlu agonist, was able to transactivate insulin-like growth factor 1 receptor (IGF-1R). We further determined that the Gi/o protein, Gβγ subunits, phospholipase C, and focal adhesion kinase (FAK) were involved in the IGF-1R transactivation signaling axis, which further induced the phosphorylation of extracellular signal-regulated kinase1/2 (ERK1/2) and cAMP response element-binding protein. In primary mouse cortical neurons, similar signaling pathways were observed when mGlu2 were stimulated by LY487379, an mGlu2 positive allosteric modulator. Transactivation of IGF-1R through FAK in response to mGlu2 should provide a better understanding of the association of mGlu2 with brain disease.

Entities:  

Keywords:  ERK1/2; FAK; LY379268; LY487379; insulin-like growth factor 1 receptor; metabotropic glutamate receptor 2; mouse cortical neurons; transactivation

Mesh:

Substances:

Year:  2018        PMID: 29946167      PMCID: PMC6461959          DOI: 10.1038/s41401-018-0033-7

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  45 in total

1.  Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors.

Authors:  F Ferraguti; B Baldani-Guerra; M Corsi; S Nakanishi; C Corti
Journal:  Eur J Neurosci       Date:  1999-06       Impact factor: 3.386

Review 2.  GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences.

Authors:  Bukhtiar H Shah; Kevin J Catt
Journal:  Trends Neurosci       Date:  2004-01       Impact factor: 13.837

3.  (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.

Authors:  Iván Collado; Concepción Pedregal; Angel Mazón; Juan Félix Espinosa; Jaime Blanco-Urgoiti; Darryle D Schoepp; Rebecca A Wright; Bryan G Johnson; Ann E Kingston
Journal:  J Med Chem       Date:  2002-08-15       Impact factor: 7.446

4.  Opposing activities protect against age-onset proteotoxicity.

Authors:  Ehud Cohen; Jan Bieschke; Rhonda M Perciavalle; Jeffery W Kelly; Andrew Dillin
Journal:  Science       Date:  2006-08-10       Impact factor: 47.728

5.  Dominant role of GABAB2 and Gbetagamma for GABAB receptor-mediated-ERK1/2/CREB pathway in cerebellar neurons.

Authors:  Haijun Tu; Philippe Rondard; Chanjuan Xu; Federica Bertaso; Fangli Cao; Xueying Zhang; Jean-Philippe Pin; Jianfeng Liu
Journal:  Cell Signal       Date:  2007-05-26       Impact factor: 4.315

6.  Insulin-like growth factor 1 regulates developing brain glucose metabolism.

Authors:  C M Cheng; R R Reinhardt; W H Lee; G Joncas; S C Patel; C A Bondy
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 7.  The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory.

Authors:  J D Sweatt
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

Review 8.  What turns CREB on?

Authors:  Mona Johannessen; Marit Pedersen Delghandi; Ugo Moens
Journal:  Cell Signal       Date:  2004-11       Impact factor: 4.315

9.  Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.

Authors:  Peter Zahradka; Brenda Litchie; Ben Storie; Gail Helwer
Journal:  Endocrinology       Date:  2004-02-19       Impact factor: 4.736

10.  Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.

Authors:  Hervé Schaffhauser; Blake A Rowe; Sylvia Morales; Laura E Chavez-Noriega; Ruoyuan Yin; Christine Jachec; Sara P Rao; Gretchen Bain; Anthony B Pinkerton; Jean-Michel Vernier; Linda J Bristow; Mark A Varney; Lorrie P Daggett
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

View more
  2 in total

Review 1.  Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity.

Authors:  Lijun Ge; Shuyuan Liu; Limor Rubin; Philip Lazarovici; Wenhua Zheng
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

Review 2.  Interactions of Glutamate and Gamma Amino Butyric Acid with the insulin-like growth factor system in traumatic brain injury (TBI) and/or cardiovascular accidents (CVA or stroke): A systematic review.

Authors:  T I Morales; K A Stearns-Yoder; A S Hoffberg; T K Khan; H Wortzel; L A Brenner
Journal:  Heliyon       Date:  2022-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.